Augmedix Performance
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Augmedix has a performance score of 13 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 2.43, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Augmedix will likely underperform. Augmedix right now shows a risk of 0.31%. Please confirm Augmedix sortino ratio, as well as the relationship between the semi variance and day typical price , to decide if Augmedix will be following its price patterns.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Augmedix are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong technical and fundamental indicators, Augmedix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 21.4 M |
Augmedix |
Augmedix Relative Risk vs. Return Landscape
If you would invest 232.00 in Augmedix on August 29, 2024 and sell it today you would earn a total of 3.00 from holding Augmedix or generate 1.29% return on investment over 90 days. Augmedix is currently generating 0.0519% in daily expected returns and assumes 0.3122% risk (volatility on return distribution) over the 90 days horizon. In different words, 2% of stocks are less volatile than Augmedix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Augmedix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Augmedix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Augmedix, and traders can use it to determine the average amount a Augmedix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1662
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | AUGX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.31 actual daily | 2 98% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Augmedix is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Augmedix by adding it to a well-diversified portfolio.
Augmedix Fundamentals Growth
Augmedix Stock prices reflect investors' perceptions of the future prospects and financial health of Augmedix, and Augmedix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Augmedix Stock performance.
| Return On Equity | -3.3 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.46) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 113.21 M | |||
| Shares Outstanding | 49.43 M | |||
| Price To Book | 11.09 X | |||
| Price To Sales | 2.25 X | |||
| Revenue | 44.85 M | |||
| EBITDA | (17.68 M) | |||
| Cash And Equivalents | 29.99 M | |||
| Cash Per Share | 0.80 X | |||
| Total Debt | 25.85 M | |||
| Debt To Equity | 1.54 % | |||
| Book Value Per Share | 0.21 X | |||
| Cash Flow From Operations | (15.44 M) | |||
| Earnings Per Share | (0.47) X | |||
| Total Asset | 66.71 M | |||
| Retained Earnings | (144.96 M) | |||
About Augmedix Performance
Evaluating Augmedix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Augmedix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Augmedix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.Things to note about Augmedix performance evaluation
Checking the ongoing alerts about Augmedix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Augmedix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Augmedix is not yet fully synchronised with the market data | |
| Augmedix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 44.85 M. Net Loss for the year was (19.17 M) with profit before overhead, payroll, taxes, and interest of 13.95 M. | |
| Augmedix currently holds about 29.99 M in cash with (15.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8. | |
| Over 85.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Augmedix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Augmedix's stock is overvalued or undervalued compared to its peers.
- Examining Augmedix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Augmedix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Augmedix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Augmedix's stock. These opinions can provide insight into Augmedix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Correlations Find global opportunities by holding instruments from different markets |